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Abstract 
Purpose: To develop an innovative method for detection of soybean allergen, Gly mBd 30K (P34) in 
foods using a biosensor based on high spatial imaging ellipsometer.  
Methods: Two monoclonal antibodies, 2D1 and 5F9, each known to have specific bioactivity against 
P34 allergen, were selected and separately immobilized as ligands on silicon wafer surface to allow 
capture of the P34 allergen. The resultant changes on the wafer surface were viewed directly as images 
in gray scale.  
Results: Images indicated that these two antibodies detected the presence of P34 allergen in soybean 
extract with sensitivity of 1 mg/L and a detection time of about 15 min. For the detection of P34 allergen 
in foods, results from biochip detection were consistent with those obtained using ELISA detection. 
Conclusion: These results show that the biochip may be an effective analytical tool for food allergen 
detection. 
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Soybean allergy is extremely important because 
soybeans are widely used in numerous food 
products and contain a particularly insidious 
hidden allergen [1]. Nearly 0.5 % of the general 
population and 3 - 6 % of children are affected by 
soybean allergy. Clinical symptoms of soybean 
allergy range from severe enterocolitis to atopic 
eczema and immediate, multi-system IgE-
mediated reactions [2]. Among the allergenic 
soybean proteins determined to date, Gly mBd 
30K (P34) is a major allergen. This 30 - 34 kDa 
protein is a low-level but highly conserved seed 
storage protein [3]. P34 is widespread in wild and 
cultivated soybeans. More than 65 % of 
soybean-allergic patients react only to the P34 
protein [4,5]. Thus, appropriate analytical 
methods are necessary for monitoring the 
presence of this allergen in foodstuffs and 
ensuring that proper labeling requirements are 
being followed. To date, enzyme-linked 
immunosorbent assay (ELISA) and polymerase 
chain reaction (PCR) have been reported and 
are commonly used for food allergen detection, 
and they have been adopted as standard 
methods of choice by food industries and food 
safety regulatory authorities [6,7]. However, 
these techniques are limited by the need for 
tracer labeling, indirect identification, and lengthy 
detection times. Biochip based on imaging 
ellipsometry, as a non-destructive and label-free 
technique for thin layer analysis [8], is so 
sensitive that it can achieve resolution for film 
thickness in the sub-nanometer region [9]. 
Previous studies have reported that it can be 
used in many different biomedical fields such as 
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biomolecular interactions, viral examinations, and 
biomarker measurements [10-13]. 
 
In the present study, we describe a biochip 
detection technology for P34 allergen in food 
products. Two monoclonal antibodies (mAbs) 
were selected against the P34 allergen, and then 
immobilized as silicon-surface ligands. The 
accuracy, sensitivity, and specificity of biochips in 




Materials and reagents 
 
Silicon wafers were obtained from the General 
Research Institute for Non-ferrous Metals in 
Beijing, China. Fast Soya ELISA kit was 
purchased from R-Biopharm (Germany); 3-
aminopropyltriethoxy-silane (APTES, 99 %, v/v) 
was product of ACROS (Geel, Belgium), while 
sulfuric acid (H2SO4, 98 %), hydrogen peroxide 
(H2O2, 30 %) and absolute ethanol (99.7 %) were 
purchased from Nanjing Chemical Reagent Co., 
Ltd. (Nanjing, China). 1-(3-dimethyla-
minopropyl)-3-ethylcarbodiimide hydrochloride 
(EDC), N-hydroxysuccinimide (NHS); glycine 
(Gly), succinic anhydride, bovine serum albumin 
(BSA), and Tween 20 were obtained from Sigma-
Aldrich (USA). P34 standard sample, two specific 
mouse IgG1 mAbs against P34 (2D1 and 5F9) 
were provided by Shenzhen University Medical 
College in Shenzhen, China. 
 
Phosphate-buffered saline (PBS, composition: 
140 mmol/L NaCl, 2.7 mmol/L KCl, 10 mmol/L 
Na2HPO4, 1.8 mmol/L KH2PO4, pH 7.3) and 
PBST (PBS with 1 % Tween 20) was prepared in 
de-ionized water (18.3 MΩcm) obtained from a 
Milli-Q Plus system (Millipore Corporation, 
Billerica, MA, USA). Samples of soybean, 
soybean milk powder, cream cake, cereal bar, 
chocolate biscuits, pineapple cake, egg, dried 
milk, shrimp, fish, peanut, wheat, and graham 
bread were obtained from local markets in 
Nanjing, China. Two mAbs against the P34 
allergen were diluted to 0.1 mg/mL with PBST. 
The blocking reagents were combined by 
dissolving 10 mg BSA and 10 mg Gly in 100 mL 




Crude P34 allergen was extracted from the 
samples in accordance with the procedure 
described by Qiao [14], with slight modifications. 
Thirty grams of each sample was homogenized 
in an IKA®A11 basic (IKA, Germany) with 30 mL 
of egg white in 100 mL of PBS (pH 7.4), and the 
homogenate was stirred for 15 min at 60°C. 
Insoluble resides were removed by centrifugation 
for 5 min at 3000 g. Then, the supernatant was 
collected and centrifuged again for 5 min at 
20,000 g. The resultant supernatant was kept at -
20 °C prior to use. Proteins in all commercial 
samples were prepared in a similar manner. 
 
Surface modification of silicon wafer 
 
Silicon wafers were cut into 2 cm ×1.5 cm 
section and rinsed with de-ionized water. The 
wafer surfaces were washed for 30 min in a 
solution containing 1:3 volume ratio of 30% H2O2 
and 98 % H2SO4. This procedure enriched the 
wafer surface with silanol groups. After rinsing 
with de-ionized water, the wafers were incubated 
for 2 h in a 1:10 volume ratio of APTES and 
absolute ethanol. The reaction of APTES with the 
silanol groups on the surface  resulted in 
covalent immobilization of –O–Si(OH)2–(CH2)3–
NH2, thereby generating densely-packed amino 
groups on the surface. After rinsing with absolute 
ethanol, the wafers were immersed for 12 h in a 
saturated solution of succinic anhydride in 
absolute ethanol. The -CH2CH2COOCO- group 
of succinic anhydride reacted with –O–Si(OH)2–
(CH2)3–NH2 immobilized on the surface, forming–
(CH2)3NH–CO(CH2)2–COOH. The processed 
wafers were kept in absolute ethanol until used. 
 
Ligand immobilization and P34 allergen 
detection 
 
When the modified wafers were put into a 
microfluidic device [15], the carboxyl groupson 
their surface were activated by EDC/NHS 
(consisting of 0.05 mol/L NHS and 0.2 mol/L 
EDC in de-ionized water at a concentration of 10 
μL per unit, and allowed to flow through the 
surface at a concentration of a 5 μL/min). The 
carboxyl groups were changed to sulfo-NHS 
ester by EDC/NHS, when they reacted with the 
amine groups of the protein. Subsequently, the 
two mAbs (2D1 and 5F9) were injected into each 
cell (10 μL per unit at 1 μL/min) and immobilized 
separately as ligands in the microarray using the 
microfluidic device. Finally, the surface of each 
unit in the microarray was blocked in the blocking 
solution (40 μL per unit at 1 μL/min). The units 
were washed with PBST (15 μL per unit at 5 
μL/min) in-between procedures. Thus, a specific 
microarray with a sensing surface array was 
prepared. P34 allergen protein or soybean 
samples were brought into contact with the 
sensing surface. In the first place, P34 allergen 
was recognized by specific ligands when it 
flowed over the sensing surface (10 μL per unit 
at 1 μL/min). Subsequently, the wafer was 
washed with de-ionized water (15 μL per unit at 5 
μL/min), and the microarray was taken out from 
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the microfluidic device. After rinsing with much 
de-ionized water and drying under nitrogen, the 
results were determined by images in gray scale. 
The capture of the P34 allergen brought about an 
increase in the gray scale value for each 
corresponding unit. The gray scale images and 
gray scale values were obtained using the 
Ellipsometric Imaging System (SE 400, 
SENTECH, Germany). 
 
Determination of sensitivity 
 
To determine the sensitivity of biochips for the 
detection of P34 allergens, soybean allergen P34 
was prepared by serial dilution using PBST to 
obtain concentrations of 25, 12.5, 6.25, 3.125 
and 1 mg/mL. Protein concentration was 
quantified using the Bradford assay. The 
concentration gradient of the P34 allergen was 
then obtained from measurement of different 
gray scale values. These results were acquired 
from four replicates at each concentration.  
 
Detection of P34 allergen in commercial 
foods 
 
To verify the specificity and accuracy of our 
analysis, soybean and soybean milk powder 
were chosen as positive controls, while egg, milk, 
shrimp, fish, peanut, wheat, and graham bread 
served as negative controls. Manufactured foods 
such as cream cake, cereal bar, chocolate 
biscuits, and pineapple cake were screened for 
presence of P34 allergen. P34 allergens from the 
commercial foods and proteins from the negative 
controls were prepared using the method of Qiao 
as described earlier [14]. The extracts were 
diluted in a volume ratio of 1:10 with PBST and 
tested in four replicates. 
 
Detection of soybean allergen using ELISA kit 
 
Protein extraction and immunochemical detection 
of soybean allergen was done in three replicates 
using commercial FAST Soya kit in accordance 




Analyses of variance (ANOVA) were carried out 
using Microcal Origin 8.0 (Microcal Software, 
Inc., Northampton, MA, USA). Data are 
presented as mean ± SD. The significance level 




Qualitative detection of P34 allergen 
 
The detectable signals of soybean allergen 
extracts were brighter than those of the blank 
control and other samples (egg, milk, shrimp, 
fish, peanut, and wheat; Figure 1A). 
Furthermore, the interactions between the 
soybean allergen P34 and two mAbs (2D1and 
 
 
Figure 1: Qualitative detection of P34 with the biochips method. Gray scale image of the different food allergens 
detected (A), and gray scale values corresponding to the gray scale images indicated in A (B). 
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5F9) could be measured with Ellipsometric 
Imaging Expert System. These results are 
indicated in Figure 1B and show that the mAbs 
(interacting with P34) have greater binding 
capacities for soybean allergen extracts than the 
other food allergens analyzed (p<0.05). 
 
Sensitivity and stability of the detection 
 
Five serially diluted concentrations of the P34 
standard sample were used to confirm the 
sensitivity (Figure 2). The results indicated that 
changes in signal strength varied directly with 
changes in concentration of the P34 allergen (1-
25 mg/L). The sensitivity of detection for P34 
levels for 2D1 and 5F9 was 1.0 mg/L. The gray 
scale values of the blank control were 56.0 ± 1.1 
and 66.2 ± 0.9, respectively, while the values of 
the negative control (milk) were 56.8 ± 1.8 and 
66.7 ± 2.7, i.e., values for 2D1 and 5F9 were 
about 1.4 and 0.75 %, respectively, higher than 
those of the blank control. The values for the 
positive sample (1.0 mg/L P34) were 62.1 ± 1.1 
and 71.5 ± 1.3, about 10.9 and 8.0 % higher than 
that of the blank controls. These values were 
approximately 9.3 and 7.2 %, respectively, higher 
than those of the negative controls. This 
indicates that the sensitivity of this assay 
reached up to 1.0 mg/L. 
 
Detection of P34 allergen in commercial 
foods 
 
Six different commercial foods were analyzed to 
further investigate the accuracy and reliability of 
biochips. The results indicated that signal 
strengths of pineapple cake, chocolate biscuits, 
cream cake, and soybean milk powder were 
brighter than those measured for blank control 
(PBST) and negative control (Graham bread), 
while the signal strength of cereal bar was almost 
the same as those of the control groups (Figure 
3A). The signal strength was also represented by 
the gray scale (Figure 3B). Commercial foods 
(pineapple cake, chocolate biscuits, cream cake, 
and soybean milk powder) had significant 
variations in gray scale values (p < 0.05), unlike 
cereal bar. To confirm the accuracy of this assay, 
these commercial foods were also analyzed by 
ELISA and, in all cases, identical results were 
obtained by both methods (Figure 3C). ELISA 
results for the cereal bar and graham bread were 
similar to those for the blank control (0 mg/kg 
soybean protein). The optical density (OD) 
values of other commercial foods were higher 
than those of the control groups (p < 0.05). 
These observations confirm that the results 
obtained by biochip were in agreement with 




Nowadays, there are few available data 
describing the threshold dose of soybean 
allergens that brings about allergic reactions. In a 
recent study on the clinical manifestations of 
soybean allergy in Europe, soybean-allergic 
individuals underwent a double-blind placebo- 
 
 
A                   B 
Figure 2: Sensitivity of biochips in detecting P34 with mAbs (2D1 and 5F9) as ligands. Gray scale images of a 
serial dilution of P34 detected (A), and average gray scale values corresponding to the gray scale images 
indicated in A (for two duplicate units) (B) 
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Figure 3: Detection of P34 in commercial food samples with the biochips method. Gray scale images of P34 
detected by biochips in commercial samples (A); average gray scale values corresponding to the gray scale 
images (for two duplicate units) (B) and ELISA for the detection of commercial foods (C) 
 
controlled food challenge test [16]. The results of 
that study showed that cumulative threshold 
doses which elicited soybean-allergic varied from 
10 mg to 50 g for subjective symptoms, and from 
454 mg to 50 g for objective symptoms. In 
another study in America, 15 out of 53 (28 %) 
soybean-allergic children with atopic dermatitis 
reacted to less than 0.5 g of soybean flour 
(equivalent to approximately 41 mg of soy 
protein) [17]. 
 
The present study confirms that the results of 
qualitative detection of P34 allergen are in 
agreement with the results obtained by ELISA 
[18]. This is indicates that the antibodies used in 
the present study were capable of specific 
detection of the P34 allergen. Moreover, the 
detection sensitivity obtained is sufficient to meet 
the demands of practical application. Practical 
applicability of the biochip method was also 
tested by analysis of six different food products, 
and the results indicated that the soybean 
ingredients in food products could be detected 
using P34 as the target protein. These results 
indicate clearly that this technique has both label-
free and high throughput characteristics, which 
shorten analysis time, exhibit high specificity and 
sensitivity, and may be used as an alternative or 
complementary method to extant 




A label-free, rapid and specific biochip has been 
presented and validated for detection and 
identification of the major soybean allergen Gly 
mBd 30K (P34).The results demonstrate that this 
assay can be used for the sensitive and 
qualitative detection of P34 allergen through a 
simple and rapid procedure. The method has 
potential for application in direct detection of 
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